(Q44202951)

30 November 2017

title

Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation (English)

1 reference

30 November 2017

5

Laurence Klotz

1 reference

30 November 2017

4

Cyril Danjoux

1 reference

30 November 2017

Peter S Bunting

1

1 reference

30 November 2017

Gerrit DeBoer

series ordinal

2

1 reference

30 November 2017

Richard Choo

series ordinal

3

1 reference

30 November 2017

Neil Fleshner

series ordinal

6

1 reference

30 November 2017

publication date

1 September 2002

1 reference

30 November 2017

published in

Clinical Biochemistry

1 reference

30 November 2017

volume

35

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

471-475

1 reference

Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

Influence of free-to-total prostate specific antigen variability on the early diagnosis of prostate cancer: a comparative study of three immunoassays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

A guide to the interpretation of serum prostate specific antigen levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

The effect of Digital Rectal Examination, Flexible Cystoscopy and Prostatic Biopsy on Free and Total Prostate Specific Antigen, and the Free-to-Total Prostate Specific Antigen Ratio in Clinical Practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

Effect of ejaculation on serum total and free prostate-specific antigen concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

Proposals for setting generally applicable quality goals solely based on biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

PSA doubling time of prostate carcinoma managed with watchful observation alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

The role of serial free/total prostate-specific antigen ratios in a watchful observation protocol for men with localized prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900345-4

10.1016/S0009-9120(02)00345-4

7 January 2021

Identifiers

DOI

1 reference

release_73ln7wjohrcbhmbshjthawoh5q

30 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/73ln7wjohrcbhmbshjthawoh5q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference